In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated that the spinal cord is far more than just a transmission pathway that ...
NervGen completed enrollment for its phase 2 trial in spinal cord injury, setting the countdown ... is what is now the focus of proof-of-concept human trials. Known as NVG-291, it is a “novel ...